The leading causes of mortality in our study were pneumonia, diseases of the circulatory
system, and dementias. In patients with hip fractures, the emphasis should be placed not …

Background: Postoperative blood product transfusions in elderly hip fracture patients cause
concern for morbidity and mortality. The purpose of this study was to identify predictors and …

Introduction: Intravenous tranexamic acid (IV TXA) is a recognised pharmaceutical
intervention utilised to minimise blood loss and allogenic blood transfusion. However, the …

Background Geriatric hip fracture patients are particularly susceptible to blood loss and
venous thromboembolism (VTE) during hemiarthroplasty, yet relatively few studies have …

Background Intravenous tranexamic acid (TA) has proven efficacy in reducing blood loss
and incidence of transfusion of blood products in elective total joint arthroplasty. However …

Objectives A post hoc gender comparison of transfusion-related modifiable risk factors
among patients undergoing elective surgery. Settings 23 Austrian centres randomly selected …

Background: Extracapsular femoral neck fractures (eFNF) are the third most common type of
fracture in traumatology. Intramedullary nailing (IMN) is one of the most frequently used …

Objectives To evaluate the roles of preoperative anemia and intraoperative blood
transfusion in the development of postoperative delirium among older patients undergoing …

Background Hip fracture patients in general are elderly and they often have comorbidities
that may necessitate anticoagulation treatment, such as warfarin. It has been emphasized …

Introduction The use of tranexamic acid (TXA) in hip fracture surgery remains inconclusive.
The aim of the present meta-analysis was to assess the role of TXA use in hip fracture …